| E-7449 |
1140964-99-3 |
1140964-99-3 |
| BMS-816336 |
BMS-816336 |
1009583-20-3 |
| SR-3306 |
化合物SR-3306 |
1128096-91-2 |
| GSK1838705A |
GSK1838705A |
1116235-97-2 |
| Z433927330 |
Z433927330 |
1005883-72-6 |
| Takinib |
1111556-37-6 |
1111556-37-6 |
| TM 5275 |
CS-2524 |
1103926-82-4 |
| Tepotinib |
特泊替尼 |
1100598-32-0 |
| LY-2562175 |
化合物LY2562175 |
1103500-20-4 |
| 3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide |
MK-8033 |
1001917-37-8 |
| (R)-N-(2-(3-((3-hydroxypyrrolidin-1-yl)Methyl)iMidazo[2,1-b]thiazol-6-yl)phenyl)-2-naphthaMide |
SRT 2183 |
1001908-89-9 |
| TZ-9 |
1002789-86-7 |
1002789-86-7 |
| GNF362 |
GNF362 |
1003019-41-7 |
| PDK1 inhibitor |
PDK1 抑制剂 |
1001409-50-2 |
| TC-S 7005 |
TC-S 7005 |
1082739-92-1 |
| 1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-, hydrochloride (1:1) |
盐酸巴多昔芬 |
198480-56-7 |
| AT-406(AT406) |
AT-406 |
1071992-99-8 |
| Debio 0932 ,CUDC-305 |
DEBIO 0932 |
1061318-81-7 |
| RO3280 |
RO3280 |
1062243-51-9 |
| WAY-600 |
6-(1H-吲哚-5-基)-4-(4-吗啉基)-1-[1-(3-吡啶基甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶 |
1062159-35-6 |
